|
|
Recent news from the US Food and Drug Administration.
Click title to see the full article at the FDA
website. For the most up-to-date headlines, check out the FDA
Newsroom. Press announcements from 2004 to 2009 are available through
the FDA
Archive.
FDA
Recalls: FDA posts press releases and other notices of recalls and
market withdrawals from the firms involved as a service to consumers,
the media, and other interested parties. FDA does not endorse either the
product or the company. This site does not contain a complete list of
recalls -
search for recalls at the official FDA site.

| August 28, 2026 - FDA
Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood
Disorder |
| August 27, 2026 - FDA
Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults |
| August 27, 2026 - FDA
Issues Emergency Use Authorization for Generic Drug to Prevent New
World Screwworm in Cattle |
| August 26, 2026 - FDA
Approves First in Class Targeted Therapy for Metastatic Pancreatic
Cancer |
| August 25, 2026 - FDA
Authorizes First Wearable Device That Continuously Monitors Both Ketone
Levels and Blood Sugar |
| August 19, 2026 - FDA
Approves First Therapy for Patients aged 8 years and older with Glycogen
Storage Disease Type Ia |
| August 19, 2026 - FDA
Authorizes First-Of-Its-Kind Robotic Blood Draw Device |
| August 18, 2026 - FDA
Seeks Public Feedback to Inform Regulatory Approach for Generative
AI-Enabled Medical Devices |
| August 13, 2026 - FDA
Issues Emergency Use Authorization for Drug to Treat New World Screwworm
in Dogs and Puppies |
| August 7, 2026 - FDA
Issues Emergency Use Authorization for Drug to Prevent New World Screwworm
in Multiple Species, Including Sheep, Cattle, Goats, and Swine |
| August 6, 2026 - FDA
Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant
Advanced Melanoma |
| August 5, 2026 - FDA
Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms |

|
|